Abstract 12851: Efficacy and Safety of Rilonacept in Recurrent Pericarditis: A Multicenter Phase 2 Clinical Trial

Circulation(2019)

引用 23|浏览37
暂无评分
摘要
Introduction: Interleukin-1 (IL-1) mediates innate autoinflammation and is implicated in recurrent pericarditis (RP). We report final data from a Phase 2 study of rilonacept (IL-1α/IL-1β inhibitor)...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要